Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery

被引:49
作者
Beyer, R
Harmening, U
Rittmeyer, O
Zielmann, S
Mielck, F
Kazmaier, S
Kettler, D
机构
[1] Dept. Anaesthiol., Emergency I., Georg-August-Univ. of Göttingen, D-37075 Göttingen
关键词
surgery; orthopaedic; fluid balance; fluids; iv;
D O I
10.1093/bja/78.1.44
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have compared 5% hydroxyethyl starch (HES 200/0.5) with 3% modified fluid gelatin (MFG) for volume replacement in major orthopaedic surgery and studied the effects on haemodynamic stare, colloid osmotic pressure, blood clotting and plasma homeostasis. Using a controlled, randomized, single-blind clinical design, we studied 46 consecutive patients undergoing major elective orthopaedic hip surgery. The two groups were comparable in age, body weight and duration of surgery. Patients were maintained haemodynamically stable using both HES and MFG over the entire study, Fluid balance and colloidal replacement volumes were comparable in both groups (median perioperative infusion volume: HES 2500 ml, MFG 2400 ml). Laboralory variables were not clinically different. We conclude that both colloidal solutions were comparable in volume efficacy and effects on plasma oncotic pressure, clotting and plasma homeostasis. In the small number of patients studied, 5% HES 200/0.5 was found to be safe when administered in amounts corresponding to the currently accepted maximum daily dose in Germany and France of 33 ml/kg body weight and 2.0 g/kg body weight, respectively.
引用
收藏
页码:44 / 50
页数:7
相关论文
共 19 条
  • [1] [Anonymous], ANN FRANCAISES ANAES
  • [2] COMPARISON OF THE HEMODYNAMIC AND OXYGEN-TRANSPORT RESPONSES TO MODIFIED FLUID GELATIN AND HETASTARCH IN CRITICALLY ILL PATIENTS - A PROSPECTIVE, RANDOMIZED TRIAL
    BEARDS, SC
    WATT, T
    EDWARDS, JD
    NIGHTINGALE, P
    FARRAGHER, EB
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (04) : 600 - 605
  • [3] DISSEMINATED INTRAVASCULAR COAGULATION DUE TO INTRAVENOUS ADMINISTRATION OF HETASTARCH
    CHANG, JC
    GROSS, HM
    JANG, NS
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1990, 300 (05) : 301 - 303
  • [4] DALRYMPLEHAY M, 1992, CLIN LAB HAEMATOL, V14, P209
  • [5] FURIC I, 1992, PHARM HOSPITALIERE F, V101, P1889
  • [6] HAASS A, 1989, CLIN HEMOREOL, V9, P475
  • [7] MACROAMYLASEMIA AFTER TREATMENT WITH HYDROXYETHYL STARCH
    KOHLER, H
    KIRCH, W
    WEIHRAUCH, TR
    PRELLWITZ, W
    HORSTMANN, HJ
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (03) : 205 - 211
  • [8] LHOSTE F, 1980, INTENS CARE MED, V6, P71
  • [9] A SEVERE COAGULOPATHY FOLLOWING VOLUME REPLACEMENT WITH HYDROXYETHYL STARCH IN A JEHOVAHS WITNESS
    LOCKWOOD, DNJ
    BULLEN, C
    MACHIN, SJ
    [J]. ANAESTHESIA, 1988, 43 (05) : 391 - 393
  • [10] MISHLER JM, 1980, INFUS KLIN ERN, V7, P96